Biosensors Market Size Expected to Reach USD 68.72 Billion by 2034

The global biosensors market is valued at USD 32.64 billion in 2025 and is projected to reach approximately USD 68.72 billion by 2034, expanding at a CAGR of 8.64% over the forecast period.

Ottawa, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Towards Healthcare, a sister firm of Precedence Research, reports that the global biosensors market size reached USD 30.04 billion in 2024 and is projected to grow USD 68.72 billion by 2034, expanding at a CAGR of 8.64%. The growing case of chronic disorders and technological breakthroughs is fueling the market expansion.

The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ https://www.towardshealthcare.com/download-sample/5453

Key Takeaways

North America was dominant in the global biosensors market share by 41% in 2024.
Asia-Pacific is expected to be the fastest-growing region during the projected period.
By technology, the electrochemical segment led the market in 2024 and is expected to grow at the fastest CAGR in the coming years.
By technology, the optical segment is expected to grow significantly during 2025-2034.
By application, the medical segment captured a major share of the global biosensors market in 2024.
By end-user, the POC testing segment held a dominating revenue share of the global market in 2024.

Market Overview & Potential

Analytical devices that couple a biological component with a transducer for the detection and quantification of specific molecules or biological entities are referred to as biosensors. These sophisticated biosensors are widely employed in blood glucose monitoring, determining infectious diseases, and drug discovery. Whereas, in 2025, the global biosensors market will experience prominent advances in nanotechnology and microfabrication that allow the development of smaller, more portable biosensors, comprising wearable sensors for continuous patient monitoring. Alongside innovations in material science, such as carbon nanotubes, metal-organic frameworks, and biopolymers, are being employed to optimize biosensor performance, especially sensitivity, stability, and durability.

What are the Key Growth Drivers of the Biosensors Market?

A major driver of the respective market is a rise in demand for point-of-care (POC) diagnostics, personalized healthcare, and remote patient monitoring. Along with this, many governments are encouraging and enhancing healthcare spending, which further promotes the adoption of innovative biosensors. On the other hand, accelerating awareness regarding the advantages of earlier disease detection and demand for customized health management are propelling the usage of home-based biosensor devices. A variety of biosensors are mainly impacting the comprehensive development of the market.

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

What are the Key Trends in the Biosensors Market?

Across the globe, medical diagnostic biosensors are boosting innovations in the overall market approaches.

In August 2025, HydroGraph partnered with Hawkeye Bio to empower a newer graphene biosensor solution for the LEAP Lung Cancer test from Ease Healthcare.
In July 2025, Sava Technologies raised $19 million in a Series A financing round to assist its wearable biosensor technology.
In April 2025, Biolinq, a healthcare technology company of biosensors, secured a $100 million Series C financing led by Alpha Wave Ventures.

What is the Significant Challenge in the Market?

Around the global biosensors market, certain major limitations are emerging, such as restricted awareness and accessibility of biosensors in a few areas. As well as this limitation, it is allied with the high expenses of biosensors, mainly in low-income regions. Besides this, a rise in the application of disposable biosensors raises issues related to their environmental impact.

Regional Analysis

Become a valued research partner with us - https://www.towardshealthcare.com/schedule-meeting

How did North America Hold the Largest Share of the Market in 2024?

In 2024, North America accounted for a major revenue share of 41% in the global biosensors market. This region is a prominent hub for biosensor research and development, with crucial investments from academic institutions, research organizations, and private companies. As well as North America has been developing innovative sensing platforms and applications, propelling the further expansion of startups and small-to-medium enterprises (SMEs) in the biosensor field.

For this market,

In June 2025, a Livingston-based medical diagnostics specialist coupled with a French manufacturer of advanced electrodes to establish next-generation biosensors and wearables.

What Made the Asia Pacific Significantly Grow in the Market in 2024?

In the upcoming years, the Asia Pacific is predicted to expand at the fastest CAGR in the global biosensors market. Currently, ASAP’s countries, including China, Japan, and India, are experiencing a huge burden of chronic disease cases, like diabetes, heart issues are boosting the broader adoption of biosensors. As well as this region is escalating rates of smartphone penetration are offering the integration of biosensors with mobile health platforms, enabling remote patient monitoring and personalized healthcare solutions. Also, the global developments in nanotechnology, miniaturization, and wireless communication are increasingly influencing ASAP’s market.

For instance,

In August 2025, Lura Health, a U.S. health tech company, entered into an investment and business partnership with SCO Group, a major company in Japan's dental technology sector, to advance intraoral health monitoring.

Segmental Insights

By technology analysis

Which Technology Led the Biosensors Market in 2024?

The electrochemical segment dominated the market in 2024 and is anticipated to expand rapidly during 2025-2034. Usually, this kind of technology offers inexpensive and portable electrochemical sensors to enable their application in point-of-care and home-based diagnostic settings, with enhanced accessibility and adoption. Also, these sensors have capabilities in high sensitivity and selectivity in analyte concentrations, making them ideal for applications, particularly in glucose monitoring in diabetes management.

On the other hand, the optical segment is estimated to witness a significant expansion in the studied years. The segment will possess the transformation of miniaturized and highly sensitive devices, the integration of optical biosensors into evolving technologies, comprising wearable medical devices and lab-on-a-chip systems. This fuels the advantages provided by optical sensors, like real-time monitoring, non-invasive detection, and faster analysis. Along with this, optical biosensors are becoming more affordable and portable, making them desirable for different applications including home healthcare.

Get the latest insights on life science industry segmentation with our Annual Membership: https://www.towardshealthcare.com/get-an-annual-membership

By application analysis

Why did the Medical Segment Dominate the Biosensors Market in 2024?

The medical segment was dominant in the market by capturing the biggest revenue share in 2024. Diverse applications of biosensors in the medical segment encompass diabetes management, which facilitates blood glucose monitoring. However, in the case of infectious disease detection, these sophisticated sensors offer quick diagnostic tests in a variety of infectious conditions, like COVID-19, influenza, and HIV. Biosensors are also employed in drug discovery to screen probable drug candidates and interpret drug-target interactions, which expands the development of new therapies. Advancing technologies are increasingly used in medical applications with benefits in expenses, portability, and sensitivity.

By end-user analysis

What Made the POC Testing Segment Dominant in the Market in 2024?

The POC testing segment led the market by accounting for a dominant share in the biosensors market in 2024. The segment is propelled by its integration with the trend of patient-oriented healthcare, which boosts individuals to actively monitor their health. Besides this, these POC tests are employed in numerous settings such as homes, clinics, and emergency rooms. This segment supports healthcare suppliers in performing diagnostics outside of traditional laboratory settings, resulting in faster results and optimized patient care. Also, their ability to minimize turnaround time and simplify workflows, especially in emergencies or resource-limited settings, is impacting overall market growth.

Browse More Insights of Towards Healthcare:

The global hernia mesh device market is valued at USD 5.63 billion in 2024 and is expected to grow to USD 6.02 billion in 2025, reaching approximately USD 11.01 billion by 2034. The market is projected to expand at a CAGR of 6.94% between 2025 and 2034.

The intravascular ultrasound (IVUS) and optical coherence tomography (OCT) market is witnessing significant growth, with revenues expected to rise substantially by the end of the forecast period spanning 2025 to 2034.

The global pacemaker market is valued at USD 5.45 billion in 2024 and is forecast to reach USD 5.66 billion in 2025, growing to around USD 7.89 billion by 2034 at a CAGR of 3.75% from 2025 to 2034.

The global veterinary ultrasound system market was valued at USD 400 million in 2023 and is projected to reach USD 845.41 million by 2034, expanding at a CAGR of 7.04% from 2024 to 2034.

The global healthcare consumables market was estimated at USD 155.40 billion in 2023 and is expected to grow to USD 225.68 billion by 2034, with a CAGR of 3.45% from 2024 to 2034.

The global peripheral nerve conduit market is valued at USD 154.42 million in 2024 and is projected to reach USD 411.58 million by 2034, expanding at a CAGR of 10.3% during the forecast period.

The global general surgery devices market stands at USD 18.44 billion in 2024, rising to USD 20.01 billion in 2025 and projected to reach approximately USD 41.57 billion by 2034, growing at a CAGR of 8.54% from 2025 to 2034.

The global medical equipment maintenance market is estimated at USD 46.16 billion in 2024, growing to USD 50.8 billion in 2025 and expected to reach USD 121.94 billion by 2034, expanding at a CAGR of 10.04% between 2025 and 2034.

The global infant biometrics market is on a growth trajectory, with revenues expected to reach substantial levels, potentially climbing into the hundreds of millions between 2025 and 2034.

The global chromatography instrumentation market is valued at USD 7.93 billion in 2024, growing to USD 8.36 billion in 2025 and projected to reach approximately USD 13.48 billion by 2034, expanding at a CAGR of 5.44% between 2025 and 2034.

Recent Developments in the Biosensors Market

In July 2025, Abbott launched its latest generation of sensor-based glucose monitoring technology, the FreeStyle Libre 3 Plus^* sensor, in Canada.
In July 2025, Trinity Biotech, a commercial-stage biotechnology company, introduced its novel flagship product, CGM+, a next-generation wearable biosensor platform designed for the $260 billion AI wearables market.
In April 2025, FaradaIC Sensors raised €4.5M for the miniaturisation and mass production of electrochemical sensors on chips.
In January 2024, Testing startup Grip Molecular aims for the launch of home-based infectious disease tests in 2027.

Biosensors Market Key Players

Abbott Laboratories
Bio-Rad Laboratories, Inc.
DexCom, Inc.
Innovative Sensor Technology
Masimo
Molecular Devices, LLC
Nova Biomedical Corporation
Oura
Royal Philips
Siemens Healthcare
smartQare
STMicroelectronics
WaveForm Diabetes
Xsensio

Segments Covered in The Report

By Technology

Electrochemical
Optical
Thermal
Piezoelectric

By Application

Medical
Cholesterol
Blood Glucose
Blood Gas Analyzer
Pregnancy Testing
Drug Discovery
Infectious Disease
Food Toxicity
Bioreactor
Agriculture
Environment
Others

By End-User

POC Testing
Home Healthcare Diagnostics
Food Industry
Research Laboratories
Security & Bio-Defense

By Region

North America
- U.S.
- Canada
Asia Pacific
- China
- Japan
- India
- South Korea
- Thailand
Europe
- Germany
- UK
- France
- Italy
- Spain
- Sweden
- Denmark
- Norway
Latin America
- Brazil
- Mexico
- Argentina
Middle East and Africa (MEA)
- South Africa
- UAE
- Saudi Arabia
- Kuwait

Immediate Delivery Available | Buy This Premium Research @ https://www.towardshealthcare.com/price/5453

Access our exclusive, data-rich dashboard dedicated to the healthcare market - built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.

Access the Dashboard: https://www.towardshealthcare.com/access-dashboard

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth.

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

Europe Region: +44 778 256 0738

North America Region: +1 8044 4193 44

APAC Region: +91 9356 9282 04

Web: https://www.towardshealthcare.com

Our Trusted Data Partners

Find us on social platforms: LinkedIn | Twitter | Instagram | Medium | Pinterest

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.